Results 101 to 110 of about 39,529 (215)

Utilizing enoxaparin in the management of STEMI

Vascular Health and Risk Management, 2007
Andrea Rubboli1, Alessandro Capecchi2, Giuseppe Di Pasquale11Division of Cardiology, Maggiore Hospital, Bologna, Italy; 2Division of Cardiology, General Hospital, Bentivoglio, ItalyAbstract: The use of enoxaparin in conjunction with thrombolysis in ST ...
Andrea Rubboli, Alessandro Capecchi, Giuseppe Di Pasquale   +2 more
doaj  

Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2015
Background In the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) trial, apixaban was noninferior to enoxaparin/warfarin in preventing recurrent symptomatic venous thromboembolism (VTE ...
Xianchen Liu, Margot Johnson, Jack Mardekian, Hemant Phatak, John Thompson, Alexander T. Cohen   +5 more
doaj   +1 more source

Analysis of Anti-Xa Concentrations in Patients on Treatment Dose Enoxaparin: a Retrospective Chart Review [PDF]

, 2013
The purpose of this retrospective chart review was to determine the correlation between full weight-based enoxaparin use and the frequency of anti-Xa concentrations within the defined therapeutic range; to ascertain if anti-Xa monitoring is being ...
Angelotti, Erik, Levine, Lauren, Pallme, Nicole, Shiltz, Dane L.   +3 more
core   +1 more source

Influence of low molecular weight heparins on immune system of surgical patients

Perioperative Medicine, 2019
Venous thromboembolic complications are potentially dangerous complications to life in patients undergoing surgical intervention. The aim of the work is to study the safety of enoxaparin thromboprophylaxis by eliciting the effect of sodium enoxaparin (
O O Budnyuk, I V Miastkivska, R Y Vododyuk, P I Pustovoyt, V O Nikolaev   +4 more
doaj   +1 more source

Access and non–access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events:Systematic review and meta-analysis [PDF]

, 2015
Background: The prognostic impact of site-specific major bleeding complications after percutaneous coronary intervention (PCI) has yielded conflicting data.
Buchan, Iain, de Belder, Mark A., Khan, Muhammad A., Kinnaird, Tim, Kwok, Chun Shing, Loke, Yoon K., Ludman, Peter F., Mamas, Mamas A, Nolan, James, Rao, Sunil V., Sperrin, Matt   +10 more
core   +1 more source

P.L.E.A.T.-Preventing Lymphocele Ensuring Absorption Transperitoneally: A Robotic Technique [PDF]

, 2017
OBJECTIVE: To reduce the risk of symptomatic lymphocele after robotic pelvic lymph node dissection (PLND), we present a novel technique, preventing lymphocele ensuring absorption transperitoneally (P.L.E.A.T.), where the peritoneum is "pleated" along its
DAL MORO, Fabrizio, Zattoni, Filiberto
core   +1 more source

Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement

Thrombosis Journal, 2011
Background Patients undergoing elective total hip replacement (THR) surgery are at an increased risk for venous thromboembolic events (VTEs). Dalteparin and enoxaparin are recommended as thromboprophylaxis for at least 10 days in these patients.
Choe Yoonhee, Jelincic Valentina, Dranitsaris George   +2 more
doaj   +1 more source

Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications

Clinical Pharmacology: Advances and Applications, 2018
Linda Tahaineh,1 Sahar M Edaily,1 Shadi F Gharaibeh2 1Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology (JUST), Irbid, Jordan; 2Department of Pharmaceutical Sciences, Faculty of Pharmacy, Jerash University,
Tahaineh L, Edaily SM, Gharaibeh SF
doaj  

Characterization of PCL and Chitosan Nanoparticles as Carriers of Enoxaparin and Its Antithrombotic Effect in Animal Models of Venous Thrombosis

Journal of Nanotechnology, 2017
This study was based on the preparation, characterization, and animal in vivo experiments performed to evaluate nanoparticles of poly(ɛ-caprolactone) (PCL) and chitosan as carriers of enoxaparin.
Lucas Bessa Prado, Stephany Cares Huber, Aline Barnabé, Fernanda Dutra Santiago Bassora, Devanira Souza Paixão, Nelson Duran, Joyce Maria Annichino-Bizzacchi   +6 more
doaj   +1 more source

Effectiveness of enoxaparin in preventing intraoperative fibrin formation during DMEK assessed in a before-and-after study

Scientific Reports
To demonstrate that enoxaparin in the irrigation saline solution can effectively prevent intraoperative fibrin formation (IFF) during Descemet membrane endothelial keratoplasty (DMEK) surgery without compromising graft viability, visual recovery, or ...
Pablo De-Arriba-Palomero, David Mingo-Botín, Jaime Etxebarría-Ecenarro, Javier Celis, María Teresa Merino-Diez, Cristina García-Tomás, Martha Stokking, Juan Álvarez de Toledo, Francisco J. Muñoz-Negrete, Francisco Arnalich-Montiel   +9 more
doaj   +1 more source